Developing advanced genomic sequencing technologies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Ultima Genomics operates as a biotechnology company.
Ultima Genomics Funding
Sign up to gain insights into Ultima Genomics funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series E | Jun 30, 2022 | 95M | ||
| Series E | Sep 29, 2021 | 150M | ||
| Series D | May 27, 2021 | 150M | ||
| Series C | Dec 07, 2020 | 122M | ||
| Series B | May 22, 2019 | 53M | ||
| Series A | Dec 28, 2017 | 31M | ||
| Series Seed | Dec 15, 2016 | 13M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Ultima Genomics Management Team
Investors
Founders Fund
Playground Global
Lightspeed Venture Partners
Khosla Ventures
General Atlantic
D1 Capital Partners
aMoon Fund
Andreessen Horowitz
Ultima Genomics Valuations & Financials
View real-time NPM data on Ultima Genomics stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Ultima Genomics
Cityblock Health
Health Care
Tech-driven care provider for communities with complex needs.
Benchling
Health Care
Cloud based platform for research and development in biotechnology.
Lyra
Health Care
Digital health startup using technology to connect companies and employees to mental health providers.
Eikon Therapeutics
Health Care
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Inari Agriculture
Health Care
Uses AI-powered predictive design and gene editing to create sustainable, nature-positive seeds for a more efficient food system.
Tessera Therapeutics
Health Care
Genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.
FAQ
We have answers
Ultima Genomics stock does not trade on public stock exchanges. Ultima Genomics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Ultima Genomics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Ultima Genomics Stock does not trade on public stock exchanges. In order to sell Ultima Genomics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Ultima Genomics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Ultima Genomics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Ultima Genomics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Ultima Genomics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Ultima Genomics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Ultima Genomics is a private company and has not had an IPO. There is currently no Ultima Genomics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Ultima Genomics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
